42 CFR 423.2300
§ 423.2300 Scope.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 423.2300, § 423.2300 Scope, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/205100
- Permanent ID
ys:prov:205100@1- SHA-256
56b5a072441791b736c1ec2f3f76e876747f104d9eb42e21ac528e5638298001
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Scope. This subpart sets forth the requirements for the Medicare coverage gap discount program based on provisions included in sections 1860D-14A and 1860D-43 of the Act, as follows:
(1) Condition for coverage of applicable drugs under Part D.
(2) The Medicare Coverage Gap Discount Program Agreement.
(3) Coverage gap discount payment processes for Part D sponsors.
(4) Provision of applicable discounts on applicable drugs for applicable beneficiaries.
(5) Manufacturer audit and dispute resolution processes.
(6) Resolution of beneficiary disputes involving coverage gap discounts.
(7) Compliance monitoring and civil money penalties.
(8) The termination of the Medicare Coverage Gap Discount Program Agreement.
(b) Applicability. The requirements of this subpart apply before January 1, 2025, and, with respect to applicable drugs dispensed prior to such date, continue to apply on and after January 1, 2025.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.